JP2024529466A5 - - Google Patents
Info
- Publication number
- JP2024529466A5 JP2024529466A5 JP2024505116A JP2024505116A JP2024529466A5 JP 2024529466 A5 JP2024529466 A5 JP 2024529466A5 JP 2024505116 A JP2024505116 A JP 2024505116A JP 2024505116 A JP2024505116 A JP 2024505116A JP 2024529466 A5 JP2024529466 A5 JP 2024529466A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- amino
- aryl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163227666P | 2021-07-30 | 2021-07-30 | |
| US63/227,666 | 2021-07-30 | ||
| US202263322914P | 2022-03-23 | 2022-03-23 | |
| US63/322,914 | 2022-03-23 | ||
| US202263344932P | 2022-05-23 | 2022-05-23 | |
| US63/344,932 | 2022-05-23 | ||
| PCT/US2022/038730 WO2023009759A2 (en) | 2021-07-30 | 2022-07-28 | Antibody-drug conjugates and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529466A JP2024529466A (ja) | 2024-08-06 |
| JP2024529466A5 true JP2024529466A5 (enExample) | 2025-08-05 |
Family
ID=85088249
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505116A Pending JP2024529466A (ja) | 2021-07-30 | 2022-07-28 | 抗体薬物コンジュゲート及びその使用方法 |
| JP2024505498A Pending JP2024529506A (ja) | 2021-07-30 | 2022-07-28 | ネクチン－４に特異的な抗体および抗体複合体、並びにそれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505498A Pending JP2024529506A (ja) | 2021-07-30 | 2022-07-28 | ネクチン－４に特異的な抗体および抗体複合体、並びにそれらの使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20250121090A1 (enExample) |
| EP (3) | EP4377320A4 (enExample) |
| JP (2) | JP2024529466A (enExample) |
| KR (2) | KR20240049858A (enExample) |
| AU (2) | AU2022319782A1 (enExample) |
| CA (2) | CA3227844A1 (enExample) |
| IL (1) | IL310432A (enExample) |
| MX (2) | MX2024001396A (enExample) |
| WO (3) | WO2023009759A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250121090A1 (en) * | 2021-07-30 | 2025-04-17 | R.P. Scherer Technologies, Llc | Antibody-Drug Conjugates and Methods of Use Thereof |
| KR20250161707A (ko) * | 2024-05-08 | 2025-11-18 | 아주대학교산학협력단 | Nectin-2에 결합하는 항체 약물 접합체 및 이의 용도 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX369148B (es) * | 2012-09-19 | 2019-10-30 | Innate Pharma | Agentes de unión kir3dl2. |
| US9310374B2 (en) * | 2012-11-16 | 2016-04-12 | Redwood Bioscience, Inc. | Hydrazinyl-indole compounds and methods for producing a conjugate |
| CN115504924A (zh) * | 2013-11-27 | 2022-12-23 | 雷德伍德生物科技股份有限公司 | 肼基-吡咯并化合物及用于生成缀合物的方法 |
| EP3373937B1 (en) * | 2015-11-09 | 2021-12-22 | R.P. Scherer Technologies, LLC | Anti-cd22 antibody-maytansine conjugates and methods of use thereof |
| KR102127421B1 (ko) * | 2017-03-21 | 2020-06-26 | 주식회사 펩트론 | Muc1에 특이적으로 결합하는 항체 및 그의 용도 |
| WO2019113248A1 (en) * | 2017-12-07 | 2019-06-13 | The Regents Of The University Of California | Anti-upar antibody-drug conjugates and methods of use thereof |
| KR20200117992A (ko) * | 2017-12-11 | 2020-10-14 | 트리페이스 리서치 앤드 디벨로프먼트 쓰리 코포레이션 | 항-cd22 항체-메이탄신 컨쥬게이트, 그것의 조합, 및 사용 방법 |
| KR102896085B1 (ko) * | 2018-01-15 | 2025-12-08 | 스티흐팅 산퀸 불드포르지닝 | 인자 h 강화 항체 및 이의 사용 |
| KR102892725B1 (ko) * | 2018-05-09 | 2025-12-01 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | 인간 넥틴4에 특이적인 항체 |
| CN119896746A (zh) * | 2019-01-23 | 2025-04-29 | R.P.谢勒技术有限责任公司 | 用于抗体-药物缀合物的含有糖苷的肽接头 |
| US20250121090A1 (en) * | 2021-07-30 | 2025-04-17 | R.P. Scherer Technologies, Llc | Antibody-Drug Conjugates and Methods of Use Thereof |
-
2022
- 2022-07-28 US US18/291,841 patent/US20250121090A1/en active Pending
- 2022-07-28 WO PCT/US2022/038730 patent/WO2023009759A2/en not_active Ceased
- 2022-07-28 CA CA3227844A patent/CA3227844A1/en active Pending
- 2022-07-28 AU AU2022319782A patent/AU2022319782A1/en active Pending
- 2022-07-28 JP JP2024505116A patent/JP2024529466A/ja active Pending
- 2022-07-28 US US18/291,897 patent/US20250101098A1/en active Pending
- 2022-07-28 CA CA3227845A patent/CA3227845A1/en active Pending
- 2022-07-28 IL IL310432A patent/IL310432A/en unknown
- 2022-07-28 MX MX2024001396A patent/MX2024001396A/es unknown
- 2022-07-28 KR KR1020247006358A patent/KR20240049858A/ko active Pending
- 2022-07-28 AU AU2022320714A patent/AU2022320714A1/en active Pending
- 2022-07-28 KR KR1020247006323A patent/KR20240040098A/ko active Pending
- 2022-07-28 MX MX2024001301A patent/MX2024001301A/es unknown
- 2022-07-28 EP EP22850336.3A patent/EP4377320A4/en active Pending
- 2022-07-28 JP JP2024505498A patent/JP2024529506A/ja active Pending
- 2022-07-28 WO PCT/US2022/038720 patent/WO2023009751A2/en not_active Ceased
- 2022-07-28 EP EP22850332.2A patent/EP4377319A2/en active Pending
- 2022-07-29 EP EP22850375.1A patent/EP4529537A2/en active Pending
- 2022-10-28 WO PCT/US2022/038904 patent/WO2023009835A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7403507B2 (ja) | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート | |
| AU2020239744B2 (en) | Hydrophilic antibody-drug conjugates | |
| JP2024512986A5 (enExample) | ||
| JP2019142870A5 (enExample) | ||
| JP7241811B2 (ja) | 四級化チューブリシン化合物の複合体 | |
| JP2022518743A5 (enExample) | ||
| JP2024529466A5 (enExample) | ||
| US10912836B2 (en) | Synthetic antibody mimetic compounds (SyAMs) targeting cancer, especially prostate cancer | |
| JP6117921B2 (ja) | 細胞毒性剤と細胞結合受容体との共役体 | |
| JP2021527040A5 (enExample) | ||
| JP2022530524A5 (enExample) | ||
| JP2018512376A (ja) | 抗体薬物コンジュゲート | |
| JP2015524796A5 (ja) | 細胞毒性剤と細胞結合受容体との共役体 | |
| JP2022541517A5 (enExample) | ||
| JP2020504180A (ja) | β−ガラクトシドが導入された自己犠牲リンカーを含む化合物 | |
| RU2009121626A (ru) | Соединения агонисты рецептора глюкагоноподобного белка-1 (glp-1r) | |
| JP2024501537A5 (enExample) | ||
| JP6585650B2 (ja) | 細胞毒性剤と細胞結合受容体との共役体 | |
| JP2024532677A5 (enExample) | ||
| JP2023551203A5 (enExample) | ||
| RU2024101910A (ru) | Конъюгаты антитела и лекарственного средства и способы их использования | |
| AU670194B2 (en) | Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease | |
| JP2025500404A5 (enExample) | ||
| RU2024116267A (ru) | Производные экзатекана, линкеры с полезной нагрузкой и их конъюгаты | |
| FR2774989A1 (fr) | Nouveaux cytotoxiques derives de l'oestradiol |